NCT01107132|UnknownDMC
Loading search results
Sponsor study identifier
observational
100
1 country
1
Study Start
May 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedIn Type 2 Diabetes mellitus patients we will:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 18, 2010
Actual (reported)April 20, 2010
Actual (reported)May 2010
Date type not reportedThis date has not been verified as actual or estimated.
T2DM Patient suffering from Non-Proliferative Diabetic Retinopathy (NPDR), Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema (DME)
Type 2 Diabetes Mellitus Patient suffering from Non-Proliferative Diabetic Retinopathy (NPDR), Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema
Soroka University Medical Center
Beersheba, Israel
• Fluorescein Angiography 1. Investigation and documentation of the retinal and choroidal vascular systems integrity by intravenous administration of sodium fluorescein 2. FA images are recorded in a central database with restricted accesses and are routinely analyzed by the eye specialist
Hadar Shalev, M.D
Soroka University Medical Center
First Submitted
April 18, 2010
First Posted
April 20, 2010
Study Start
May 2010
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
April 20, 2010
Record last verified: 2010-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Type 2 Diabetes Haptoglobin Phenotype and Vitamin E
Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic Patients
Contact the study team to confirm eligibility.